Compass Therapeutics : 2024 Proxy Supplemental
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy...
Source: marketscreener.com
Thomas Schuetz News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Thomas Schuetz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Thomas Schuetz Today - Breaking & Trending Today
Bispecific Antibody Fast Tracked for Advanced Biliary Tract Cancer
CTX-009 is a bispecific antibody that simultaneously blocks Delta-like ligand 4 and vascular endothelial growth factor A.
Source: empr.com
FDA Grants Fast Track Designation to CTX-009 in Biliary Tract Cancer
The combination of bispecific antibody CTX-009 and chemotherapy received Fast Track Designation for advanced, previously treated biliary tract cancers.
Source: curetoday.com
Compass Therapeutics Gets FDA Fast-Track for Cancer Treatment
By Dean Seal Compass Therapeutics said regulators have granted fast-track designation to its CTX-009 antibody in combination with paclitaxel for the treatment of biliary tract cancer. The...
Source: marketscreener.com
FDA Grants Fast Track Designation to CTX-009 Plus Paclitaxel for Pretreated Biliary Tract Cancer
CTX-009 plus paclitaxel has received FDA fast track designation for pretreated metastatic or locally advanced biliary tract cancer.
Source: onclive.com